We are live on ! Find out more
NAGE icon

Niagen Bioscience

156 hedge funds and large institutions have $418M invested in Niagen Bioscience in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 75 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 25

172% more capital inflows, than outflows

Capital inflows: $68.6M | Capital outflows: $25.2M

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

12% more funds holding

Funds holding: 139 → 156 (+17)

10% more call options, than puts

Call options by funds: $3.47M | Put options by funds: $3.14M

4.82% more ownership

Funds ownership: 32.02% → 36.84% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
156
Holders Change
+17
Holders Change %
+12.23%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
37
Increased
75
Reduced
25
Closed
21
Calls
$3.47​M
Puts
$3.14​M
Net Calls
+$323​K
Net Calls Change
-⁠$1.42​M

NAGE Hedge Fund Activity: Q2 2025 in Review

156 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2025, worth a combined $418M — up 143% from $172M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new NAGE positions and 21 closed out — a net gain of 16 holders — while 75 added to existing stakes and 25 trimmed.

The largest buyer was Nuveen, adding an estimated $8.29M. The largest seller was Millennium Management, cutting an estimated $4.73M.

  • 156 institutional investors held Niagen Bioscience (NAGE) as of Q2 2025, up from 139 in Q1 2025.
  • Funds reported $418M of Niagen Bioscience stock for Q2 2025, up 143% quarter-over-quarter.
  • 37 funds opened new Niagen Bioscience positions in Q2 2025 and 21 closed out, a net change of +16 holders.
  • The largest Niagen Bioscience buyer in Q2 2025 was Nuveen, an estimated $8.29M added.
  • The largest Niagen Bioscience seller in Q2 2025 was Millennium Management, an estimated $4.73M sold.

Based on aggregated 13F filings for Q2 2025.